Cargando…
Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
In the past years, numerous new fatal infections have emerged, including Ebola, Nipah, and Zika viruses, as well as coronaviruses. Recently, infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged in China, and were then transmitted all over the world, causing the c...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889804/ https://www.ncbi.nlm.nih.gov/pubmed/35283984 http://dx.doi.org/10.4314/ahs.v21i4.11 |
_version_ | 1784661489604362240 |
---|---|
author | El-Masry, Eman A |
author_facet | El-Masry, Eman A |
author_sort | El-Masry, Eman A |
collection | PubMed |
description | In the past years, numerous new fatal infections have emerged, including Ebola, Nipah, and Zika viruses, as well as coronaviruses. Recently, infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged in China, and were then transmitted all over the world, causing the coronavirus disease-19 (COVID-19) pandemic, which is transmitted at a higher rate than other diseases caused by coronaviruses. At the time of writing this review, COVID-19 is not contained in most countries in spite of quarantine, physical distancing, and enhanced hygiene measures. In this review, I address different methods for passive and active immunization against this virus, which is known to cause fatal respiratory disease, including natural passive immunization by breast milk, natural active immunization by herd immunization, artificial passive immunization by convalescent plasma or monoclonal antibodies, and artificial active immunization by vaccination. I hope this review will help design a prophylactic approach against outbreaks and pandemics of related coronaviruses in the future. |
format | Online Article Text |
id | pubmed-8889804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Makerere Medical School |
record_format | MEDLINE/PubMed |
spelling | pubmed-88898042022-03-10 Immunization against severe acute respiratory syndrome Coronavirus 2: an overview El-Masry, Eman A Afr Health Sci Articles In the past years, numerous new fatal infections have emerged, including Ebola, Nipah, and Zika viruses, as well as coronaviruses. Recently, infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged in China, and were then transmitted all over the world, causing the coronavirus disease-19 (COVID-19) pandemic, which is transmitted at a higher rate than other diseases caused by coronaviruses. At the time of writing this review, COVID-19 is not contained in most countries in spite of quarantine, physical distancing, and enhanced hygiene measures. In this review, I address different methods for passive and active immunization against this virus, which is known to cause fatal respiratory disease, including natural passive immunization by breast milk, natural active immunization by herd immunization, artificial passive immunization by convalescent plasma or monoclonal antibodies, and artificial active immunization by vaccination. I hope this review will help design a prophylactic approach against outbreaks and pandemics of related coronaviruses in the future. Makerere Medical School 2021-12 /pmc/articles/PMC8889804/ /pubmed/35283984 http://dx.doi.org/10.4314/ahs.v21i4.11 Text en © 2021 El-Masry EA. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles El-Masry, Eman A Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title | Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title_full | Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title_fullStr | Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title_full_unstemmed | Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title_short | Immunization against severe acute respiratory syndrome Coronavirus 2: an overview |
title_sort | immunization against severe acute respiratory syndrome coronavirus 2: an overview |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889804/ https://www.ncbi.nlm.nih.gov/pubmed/35283984 http://dx.doi.org/10.4314/ahs.v21i4.11 |
work_keys_str_mv | AT elmasryemana immunizationagainstsevereacuterespiratorysyndromecoronavirus2anoverview |